Cite

HARVARD Citation

    Constantine, G. et al. (2020). TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial. Menopause. 27 (11), p. . [Online]. 
  
Back to record